Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...

For adults with average cancer risk, a blood test could provide an option for colon cancer screening instead of a colonoscopy.

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...

Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial ...

After facing colorectal cancer for nearly eight years, Mandy Wilk got a double-lung transplant in June at Northwestern. She ...

Many people are simply unaware of the existence of the FIT test or underestimate its importance in colorectal cancer ...

Merck & Co Inc (NYSE:MRK) released topline data from the KEYFORM-007 Phase 3 study of the fixed-dose combination of ...

Created by Guardant Health, the blood test, known as Shield, was able to detect 83% of colorectal cancers in studies but only 13% of dangerous polyps. Colonoscopies find approximately 95% of these ...

An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic colorectal cancer market has ended in failure.

"Stool-based test offers a promising solution to reduce the burden of a colonoscopy," experts emphasized on September 21st, ...

Factors related to sex and gender can affect therapy outcomes and should not be overlooked in clinical practice or research.

Researchers also noticed that the mice used as models for Alzheimer’s disease who were given stool transplants from healthy ...